Accéder au contenu
Merck

6,6-Spiroimine analogs of (-)-gymnodimine A: synthesis and biological evaluation on nicotinic acetylcholine receptors.

Organic & biomolecular chemistry (2011-10-26)
Leslie Duroure, Thierry Jousseaume, Rómulo Aráoz, Elvina Barré, Pascal Retailleau, Laurent Chabaud, Jordi Molgó, Catherine Guillou
RÉSUMÉ

Simple models of the spiroimine core of (-)-gymnodimine A have been synthesized in racemic and optically active forms. The quaternary carbon of the racemic spiroimines was created by Michael addition of a β-ketoester to acrolein, whereas the asymmetric allylic alkylation of the same β-ketoester was used to access the spiroimines in an enantioselective fashion. Both racemic and enantio-enriched mixtures were tested for their biological activities on Xenopus oocytes either expressing (human α4β2) or having incorporated (Torpedoα1(2)βγδ) nicotinic acetylcholine receptors (nAChRs). These spiroimine analogs of (-)-gymnodimine A inhibited acetylcholine-evoked nicotinic currents, but were less active than the phycotoxin. Our results reveal that the 6,6-spiroimine moiety is important for the blockade of nAChRs and support the hypothesis that it is one of the pharmacophores of this group of toxins.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Vinylboronic acid pinacol ester, contains phenothiazine as stabilizer, 95%